250+ investors that invest in your industry and stage
Transportation
Gaming
Community
Proptech
FinTech
Biotech
Climate
Marketplace
Artificial intelligence
Energy
Hardware
Media (entertainment)
EdTech
Consumer
Health Care
Impact
Enterprise
Agriculture (agtech)
Sustainability
Venture Capital
Restaurants
Fashion
Real Estate
Retail
Infrastructure
Mobile Apps
Beauty
LGBT
Web3
Publishing
Clean Energy
Sporting Goods
Oil and Gas
B2B
Education
Organic Food
Big Data
Renewable Energy
Food and Beverage
Cryptocurrency
Finance
Video Games
Financial Services
Payments
Photography
Celebrity
Art
Medical
Digital Media
Music
Internet
Social Media
Manufacturing
Facebook
Franchise
Blockchain
Legal
Android
Social Impact
Mobile
Google
Construction
Sports
Local
eSports
Enterprise Software
Email
Wellness
Social Network
Hospitality
Travel
Fitness
Mobile Advertising
Cannabis
Recruiting
Platforms
Biotechnology
Medical Device
Wine And Spirits
Automotive
Crowdfunding
Social
CleanTech
InsurTech
SaaS
Software
Film
Theatre
Life Science
Non Profit
Qatar
New Zealand
United States
South Korea
Germany
Australia
India
United Kingdom
Ireland
Canada
Africa
Asia
LATAM
Europe
Oceania
Middle East
China
South Africa
Singapore
Brazil
Japan
Indonesia
Sri Lanka
Vietnam
Spain
Saudi Arabia
Argentina
Armenia
Austria
Bangladesh
Bahrain
Belarus
Bulgaria
Belgium
Bermuda
Chile
Cameroon
Switzerland
Colombia
Belize
Costa Rica
Denmark
Ecuador
Algeria
Czech Republic
Georgia
Estonia
Egypt
Ghana
Hong Kong
Ethiopia
Gibraltar
Faroe Islands
Greece
Finland
Croatia
France
Hungary
Barbados
Kuwait
Italy
Jersey
Israel
Lebanon
Cambodia
Kenya
Cayman Islands
Jordan
Lithuania
Liberia
Liechtenstein
Myanmar
Kazakhstan
Mali
Morocco
Norway
Malaysia
Mexico
Panama
Malta
Mauritius
Peru
Philippines
Nicaragua
Pakistan
Poland
Russian Federation
Romania
Sweden
Rwanda
Serbia
Seychelles
Turkey
Togo
Puerto Rico
Slovenia
Sierra Leone
San Marino
Senegal
Tunisia
Tanzania
Tajikistan
El Salvador
Uganda
Zambia
Uzbekistan
Thailand
Taiwan
Ukraine
Uruguay
Zimbabwe
Venezuela
Portugal
Azerbaijan
Bahamas
Guatemala
Iraq
Iceland
Namibia
Nigeria
United Arab Emirates
Honduras
Bolivia
Isle of Man
Luxembourg
Cyprus
Latvia
Oman
Angel investors
VC Funds
All investors
Download Find emails Save list

Top 50 Medical VC (Venture Capital) Funds in Belgium in October 2023

A list of 50 VC (Venture Capital) funds that invest in Medical startups based in Belgium. We rank investors based on the number of investments they made in Medical companies from Belgium. We update this investor list every month.

Top 50 Medical VC (Venture Capital) Funds in Belgium in October 2023

Investor Medical Belgium investments
Meusinvest (Noshaq) 8
Limburgse Reconversie Maatschappij 6
Newton Biocapital 5
Capricorn Partners 5
V-Bio Ventures 4
Qbic Fund 4
S.R.I.W. 4
Volta Ventures 3
Fund+ 3
WING by Digital Wallonia 3
GoBeyond 3
Gemma Frisius Fund 3
BAN Vlaanderen 2
White Fund 2
Buysse & Partners 2
Sambrinvest 2
Omnes Capital 2
BioGeneration Ventures 2
Inventures SA 2
Be Angels 2
Thuja Capital 2
Spinventure 2
Noshaq 2
PMV 2
Mérieux Equity Partners 1
Gimv 1
Quest for Growth 1
BIP Investment Partners 1
New Rhein 1
Financière Spin-Off Luxembourgeoise 1
LeanSquare 1
NV Industriebank LIOF 1
BNP Paribas Fortis 1
Yonjin Venture 1
Delta Partners 1
Vinnof 1
Sofinnova Investments 1
EQT life science 1
CPH Banque 1
Forbion Capital Partners 1
Sofinnova Partners 1
Hunza Ventures 1
Investsud 1
Ackermans & van Haaren 1
High-Tech Grunderfonds 1
Flanders Future Techfund 1
Dental Innovation Alliance 1
SFPI-FPIM 1
Limburg Startup 1
The CoFoundry 1

Get 300+ niche investors in 2 minutes.

Find who invests in your industry, stage, and region in our 200k+ database with AI-powered matching.

Find investors — It's Free!

Trusted by 21,000+ founders from:

Y Combinator Techstars Antler Pioneer On Deck
Investor list
Meusinvest (Noshaq)
VC Fund · Liège, Liege, Belgium · 10 investments in the past 12 months

Noshaq offers financial services to help businesses develop.

Show more...

Investment focus

  • Health Care, Biotechnology, Medical
  • Seed, Series A, Funding Round
  • Belgium, France, Germany

Portfolio highlights

  • Axithra — Saving lives and improving health economics through significant advancement of therapeutic drug monitoring (TDM).
  • RISORCE — RISORCE fills a need in Belgium for local solutions for processing tire waste while remaining dedicated to a circular economy strategy. We provide a regionally-based, technologically and environmentally sound solution.
  • Allegro Biotech — Allegro has developed the world’s-first custom-tailored, durable, biocompatible, anisotropic, regenerative meniscus cartilage, providing immediate support while also leverage the body’s own healing potential to regenerate human cartilage (proliferation and differentiation of fibrochondrocyte cells).
Show more investments...

Limburgse Reconversie Maatschappij
VC Fund · Hasselt, Limburg, Belgium · 2 investments in the past 12 months

Oxygen for growth - LRM

Show more...

Investment focus

  • Information Technology, Software, Biotechnology
  • Funding Round, Series A, Seed
  • Belgium, United States, The Netherlands

Portfolio highlights

  • Qviro — Compare industrial robotics and brands based on user ratings, product prices, use-cases. Reviews for Collaborative robots, Cobots, Industrial robots
  • Cumul.io — Create powerful dashboards in minutes. Share with your teams, or integrate in your platform. Drive growth in your business today!
  • MobieTrain — The mobile microlearning platform of Mobietrain improves knowledge retention with personalised, gamified learning to boost your sales.
Show more investments...

Newton Biocapital
VC Fund · Brussels, Brussels Hoofdstedelijk Gewest, Belgium · 4 investments in the past 12 months

Our mission is to mature innovation and support the growth of our portfolio companies to create value for patients, society, local ecosystems, and investors.

Show more...

Investment focus

  • Biotechnology, Medical, Health Care
  • Series A, Funding Round, Seed
  • Belgium, Japan, France

Portfolio highlights

  • AdipoPharma — By harnessing the power of the Adipocyte AdipoPharma is committed to developing innovative treatment for type 2 diabetes
  • AbolerIS Pharma — AbolerIS Pharma aims to develop novel and unique therapeutic approaches to induce immune tolerance.
  • Santero Therapeutics — Santero Therapeutics seeks to provide novel medications with fresh modes of action that combat diseases with high resistance. Santero develops antimicrobials with novel modes of action to combat the rise of antibiotic-resistant microorganisms.
Show more investments...

Capricorn Partners
VC Fund · Leuven, Vlaams-Brabant, Belgium · 7 investments in the past 12 months

Capricorn Partners is a unique independent manager of venture capital, growth capital and quoted equity funds

Show more...

Investment focus

  • Biotechnology, Health Care, Software
  • Funding Round, Series B, Series A
  • Belgium, United States, The Netherlands

Portfolio highlights

  • Chainels — The tenant experience app for every property in your portfolio. Save time, gain insights and collaborate with your tenants all in one place.
  • VoxelSensors — Novel sensor architecture designed for low latency and low power 3D perception.
  • fruitcore robotics — fruitcore robotics is a robotic system that leverages intelligent software and innovative mechatronics.
Show more investments...

V-Bio Ventures
VC Fund · Gent, Oost-Vlaanderen, Belgium

Achieving global impact in effective healthcare & sustainable agriculture by helping talented entrepreneurs / scientist set up exceptional companies.

Show more...

Investment focus

  • Biotechnology, Health Care, Medical
  • Series A, Series B, Seed
  • Belgium, France, United Kingdom

Portfolio highlights

  • AstriVax — AstriVax aims for initial clinical validation of the platform technology, to develop a broad vaccination pipeline.
  • Precirix — Developing radio-immunotherapeutic drugs for cancer patients.
  • Sibylla Biotech — Sibylla Biotech developed small molecule folding interfering degraders (FIDs) that can address a range of therapeutic areas.
Show more investments...

Qbic Fund
VC Fund · Belgium, Wisconsin, United States · 2 investments in the past 12 months

The Qbic Fund is a multi-sector fund supporting spin-off companies of the Ghent, Brussels and Antwerp university associations and of VITO. Through its strategic partnership with the universities of Ghent, Brussels and Antwerp, and VITO, the Qbic Fund has early and privileged access to promising research projects at these partner universities. Ourinvestment approach is based on early in-depth and independent review and analysis followed by hands on involvement and support.In May 2012 the Qbic Fund held its first close and currently it has over € 30 million under management. The Qbic Fund is backed by several public and private investors and managed by Qbic Venture Partners.

Show more...

Investment focus

  • Biotechnology, Software, Health Care
  • Seed, Funding Round, Series A
  • Belgium

Portfolio highlights

  • VoxelSensors — Novel sensor architecture designed for low latency and low power 3D perception.
  • Morrow Optics — Looking for the next big thing in eyewear technology? Check out Morrow's electrified progressives, also known as autofocals! These innovative glasses switch focus length with a touch of button, providing you with seamless vision from near to far. Learn more about this technology on Morrow's website.
  • Swave Photonics — Our mission is to bring the metaverse to life and enable display manufacturers and content creators to disrupt the visualization market with immersive, ultra-high-resolution, lifelike, true holographic displays.
Show more investments...

S.R.I.W.
VC Fund · Liège, Liege, Belgium · 4 investments in the past 12 months

The S.R.I.W. Group is an institution at the heart of the financial market that assists entrepreneurs in creating and developing businesses in the Walloon region. It reflects the effort of Wallonian industry in facing the challenges of the creation of economic value in the 21st century. Since its creation in 1979, the Société Régionaled’Investissement de Wallonie has continuously been expanding its abilities to adapt and anticipate as well as its flexibility in order to meet the requirements of its partners who are confronted with the evolution of the world economy. The principles of good governance, a strong business culture and shared values at the heart of the Group constitute important assets to capture the changing realities of the market and progress in a sustainable development perspective.

Show more...

Investment focus

  • Health Care, Biotechnology, Manufacturing
  • Funding Round, Series A, Series B
  • Belgium, United States, Spain

Portfolio highlights

  • Univercells — Univercells delivers novel biomanufacturing platforms and solutions aiming at making biologics available & affordable to all.
  • Intressa Vascular — Intressa Vascular SA is a medical device company committed to providing innovative solutions to life-threatening cardiovascular conditions such as aortic dissection
  • Santero Therapeutics — Santero Therapeutics seeks to provide novel medications with fresh modes of action that combat diseases with high resistance. Santero develops antimicrobials with novel modes of action to combat the rise of antibiotic-resistant microorganisms.
Show more investments...

Volta Ventures
VC Fund · Gent, Oost-Vlaanderen, Belgium · 8 investments in the past 12 months

Volta Ventures is a venture capital firm, offering seed & early stage VC for internet & software companies (SaaS) in the Benelux region

Show more...

Investment focus

  • Software, Information Technology, Artificial Intelligence
  • Seed, Series A, Funding Round
  • Belgium, The Netherlands, Luxembourg

Portfolio highlights

  • Next Gate Tech — Next Gate Tech is a Luxembourg based, data-driven FundTech that provides innovative Software-as-a-Service solutions for the asset management industry. Our mission is to enhance the Fund industry technology, thanks to machine learning, data analytics, and smart automation. We capitalize on the rapid emergence of cloud-based computing frameworks tooffer fast, accurate, and robust solutions to our clients. We provide intelligent, adaptive, and dynamic automation solutions through a web platform to help industry players manage middle and back-office processes.
  • Propellant.digital — We are a Netherlands based FinTech that is focused on bring together public and private data to power business decisions in a low cost way. Born in 2021, our mission is to organise financial markets information and make it transparent, accessible, affordable and useful to all parties in the ecosystem. Propellant.Digital is headed up by foundersVincent Grandjean, and Allan Horgan, both professionals who have a long history in the financial market technology sector and wanted to leverage their experience to create a solution that was low cost.
  • Ecochain Technologies — Ecochain is a life cycle assessment software and services company that helps companies reduce their environmental footprint. Learn more.
Show more investments...

Fund+
VC Fund · Leuven, Vlaams-Brabant, Belgium · 1 investment in the past 12 months

Fund+ is a venture capital firm that invests in companies operating in the diagnostics, therapeutics, medical devices, and life science sectors. The firm wants to create sustainable shareholders' value, contribute to the development of a leadership position in the life sciences sector, and generate a tangible, beneficial societal impact.Fund+ was established in 2015 and is based in Leuven, Belgium.

Show more...

Investment focus

  • Biotechnology, Health Care, Therapeutics
  • Series A, Series B, Series C
  • Belgium, United States, Spain

Portfolio highlights

  • eTheRNA immunotherapies — eTheRNA immunotherapies is developing first in class mRNA immunotherapies for the treatment of cancer and infectious diseases.
  • AstriVax — AstriVax aims for initial clinical validation of the platform technology, to develop a broad vaccination pipeline.
  • Novadip Biosciences — Novadip Biosciences, an advanced biopharmaceutical company focused on new generation of therapies from adipose stem cells adapted to hard and soft tissues reconstruction.
Show more investments...

WING by Digital Wallonia
VC Fund · Liège, Liege, Belgium · 3 investments in the past 12 months

W.IN.G by Digital Wallonia invests in SAAS, advanced tech and deep tech startups (AI, drones, medtech, IOT,...). W.IN.G brings smart money by helping startups by bi-weekly interactions and providing an operating teams (seasonal entrepreneurs being hands-on with the portfolio).

Show more...

Investment focus

  • Software, Health Care, Internet
  • Seed, Convertible Note, Series A
  • Belgium

Portfolio highlights

  • IONNYK — IONNYK is a new medium of art photography, containing millions of tiny ink capsules.
  • MYOCENE — Myocene is a Liège-based sports technology company which creates unique and innovative devices for measuring muscle fatigue and performance.
  • Verbolia — The SEO game-changer for e-commerce, helping retailers reclaim top organic search rankings. Discover untapped long-tail keywords from your product catalog and auto-generate SEO optimized pages at scale.
Show more investments...

GoBeyond
VC Fund · Zürich, Zurich, Switzerland · 1 investment in the past 12 months

GoBeyond is a FinTech company transforming angel investing into a new scalable asset class for small and large, novice to experienced investors. It offers a unique deal platform, portfolio tools, syndication/pooling, due diligence, investment monitoring services, training and certified deal leaders.Its clients are individuals, familyoffices, professional groups and corporations. It is active in the EU, Switzerland and the US. GoBeyond also offers educational training modules for angel investors in 11 categories.

Show more...

Investment focus

  • Information Technology, Medical, Software
  • Funding Round, Seed, Series A
  • Switzerland, Germany, United Kingdom

Portfolio highlights

  • LEND — LEND provides peer to peer lending in Switzerland. It connects investors with borrowers. Moreover, investors earn substantial returns and borrowers benefit from low interest rates. The company is based in Switzerland and it was founded in 2015.
  • AVAtronics — AVA Active Noise Cancellation (ANC) Solution is a breakthrough in Audio Industry. AVA is the first and only TRUE WIDE-BAND ANC in the market capable of selectively cancelling all annoying noises we want to get rid of without compromising the quality of Music or speech.
  • Blumer — Blumer is a social networking platform that provides social networks that can monetize time by consuming advertisements, selling nfts, and making crypto transactions. It offers social networks, crypto, digital marketing, and blockchain.
Show more investments...

Gemma Frisius Fund
VC Fund · Leuven, Vlaams-Brabant, Belgium · 3 investments in the past 12 months

Gemma Frisius Fund KU Leuven is a seed capital fund that aims to stimulate the creation and growth of university related spin-off companies.

Show more...

Investment focus

  • Biotechnology, Health Care, Therapeutics
  • Seed, Series B, Series A
  • Belgium, France

Portfolio highlights

  • DName-iT — DName-iT is a genetic analysis tool that offers DNA-based barcode labeling technology and a software platform that can ensure reliable, cost-effective NGS specimen identification.
  • MyCellHub — MyCellHub.com is a pre-startup from the KULeuven in the biotherapeutics industry that aspires to reform the way cell production processes are organised. With a regulatory compliant Saas-platform for data management and analytics, we increase the efficiency of your manufacturing processes, provide actionable insights via cell culture specificprocess analytics and facilitate regulatory compliance by means of a real-time audit trail and automated batch records.
  • Rewind Therapeutics — Rewind Therapeutics is a developer of novel therapeutics intended to facilitate the treatment for neurological diseases.The company's first-in-class remyelinating therapeutics block inhibitory signals that prevent the expansion and migration of oligodendrocyte stem cells in order to promote effective remyelination, enabling medicalpractitioners to treat patients suffering from multiple sclerosis and other myelin-related diseases with efficacy.
Show more investments...

BAN Vlaanderen
VC Fund · Hasselt, Limburg, Belgium

BAN Vlaanderen is the business angel network in Flanders, a value-added platform within which new or growing businesses are brought into contact with informal private investors, called Business Angels. Looking for venture capital This Business Angels bring not only money but also their own know-how, experience and contacts. Are connecting servicesoffered. Both the entrepreneurs and the business angelsBAN Vlaanderen is no investment, it does not own shares or take any investment decisions, nor for its own account or on behalf of the affiliates. Instead, it is a market where supply and demand are brought together. The information on this site is intended to initiate the purpose and operation of BAN Vlaanderen. For more information you can always contact one of our regional offices.BAN Vlaanderen is an association that aims to stimulate the development, support and promotion of entrepreneurship and investment culture in Belgium. Economic growth in Belgium

Show more...

Investment focus

  • Health Care, Medical, Apps
  • Funding Round, Seed, Series A
  • Belgium

Portfolio highlights

  • TheraSolve — TheraSolve NV is a medical technology company dedicated to developing and commercializing innovative, user-friendly, and cost-effective solutions to promoting medication adherence. TheraSolve’s patented technology platform will motivate broad patient populations to take their medications as prescribed, and more generally, to perform anyhealth-promoting activity in a timely fashion.
  • Pom — POM stands for Peace of Mind. And it's exactly that worry-free feeling that they want their customers to achieve through their invoice management solutions, both for the receiver and the sender.Their goal is to eliminate the senseless time and effort spent because of inefficient systems. And thus freeing up time to do the things that reallymatter.
  • Oncomfort — Oncomfort’s solution for digital sedation is a completely new method for relieving patients’ pain and anxiety before, during and after medical procedures. This revolutionising digital therapy combines clinical hypnotherapy and integrative therapeutic techniques through Virtual Reality.
Show more investments...

White Fund
VC Fund · 3 investments in the past 12 months

For game changers in medtech

Show more...

Investment focus

  • Health Care, Medical, Medical Device
  • Seed, Series A, Series B
  • Belgium

Portfolio highlights

  • Axithra — Saving lives and improving health economics through significant advancement of therapeutic drug monitoring (TDM).
  • Minze Health — Minze Health is a health tech start-up that builds creative digital health solutions for urology, pelvic health, and (in)continence care.
  • Intressa Vascular — Intressa Vascular SA is a medical device company committed to providing innovative solutions to life-threatening cardiovascular conditions such as aortic dissection
Show more investments...

Buysse & Partners
VC Fund · Antwerpen, Antwerpen, Belgium

Buysse and Partners is a private equity investment group based in Antwerpen that offers smart equity, a growth fund, and partnerships.

Show more...

Investment focus

  • Software, Cloud Computing, FinTech
  • Series A, Seed, Funding Round
  • Belgium, United Kingdom, The Netherlands

Portfolio highlights

  • Twikit — Twikit is an enterprise software company with a sharp focus on mass customization and digital manufacturing. We set new standards on how brands and enterprises conceptualize and manufacture products: customizable, on demand and digitally manufactured. The company has its HQ in Antwerp - Belgium and commercial offices in New York City and Stuttgart.The core differentiator of Twikit is the combined knowledge of software, product engineering for digital manufacturing and digital business chains. We work with our partners across the world to enable advanced product individualization by offering seamless end-to-end solutions from ideation to full integration with our enterprise software solutions. Our unique strength is that we integrate product parametrization and UX with digital manufacturing and mass customization at scale into any (existing) business and digital manufacturing flow.
  • Bluebee — Delivering a streamlined way for users to analyze, explore, and manage large-scale genomics data in the cloud.
  • moonbird — HealthTech, Mindfulness, Hardware, Better breathing
Show more investments...

Sambrinvest
VC Fund · Gosselies, Hainaut, Belgium · 4 investments in the past 12 months

Sambrinvest is an active venture capital player in the region of Charleroi - Thuin.

Show more...

Investment focus

  • Biotechnology, Health Care, Information Technology
  • Seed, Series A, Series B
  • Belgium, France, Spain

Portfolio highlights

  • cikisi — Specialized in Web Intelligence (collecting, searching and filtering web information). Help companies and organizations to take advantage of Web information that are relevant to their development. Develops and commercializes Cikisi WMT, a Web Intelligence Solution.
  • AbolerIS Pharma — AbolerIS Pharma aims to develop novel and unique therapeutic approaches to induce immune tolerance.
  • Santero Therapeutics — Santero Therapeutics seeks to provide novel medications with fresh modes of action that combat diseases with high resistance. Santero develops antimicrobials with novel modes of action to combat the rise of antibiotic-resistant microorganisms.
Show more investments...

Omnes Capital
VC Fund · Paris, Ile-de-France, France · 9 investments in the past 12 months

Omnes, "Powering Entrepreneurs" is a Leading private equity firm dedicated to energy transition and innovation.

Show more...

Investment focus

  • Software, Biotechnology, Health Care
  • Series A, Funding Round, Series B
  • France, United States, Belgium

Portfolio highlights

  • Iktos — Iktos is the only company to offer generative modeling with built-in synthetic accessibility for successful drug discovery
  • DiogenX — We incorporated DiogenX with the objective to provide new therapeutic solutions for diabetic patients. With Patrick Collombat and the team, we are focused on developing a first-in-class regenerative treatment for type 1 diabetes. Benjamin Charles CEO See the team News See more Our Work OUR APPROACH ABOUT DIABETES
  • The Exploration Company — For Space & Non-Space Industries.
Show more investments...

BioGeneration Ventures
VC Fund · Naarden, Noord-Holland, The Netherlands · 4 investments in the past 12 months

Shaping new life-science ventures.

Show more...

Investment focus

  • Biotechnology, Therapeutics, Health Care
  • Funding Round, Series A, Series B
  • The Netherlands, United States, United Kingdom

Portfolio highlights

  • VarmX — VarmX is a pharmaceutical spin-off from the Leiden University Medical Center. The mission of VarmX is to develop and manufacture therapeutic proteins to instantaneously restore blood clotting in bleeding patients. The lead product in the pipeline of VarmX is PseudoXa. PseudoXa is a modified recombinant human coagulation factor X which is capable ofimmediately restoring blood clotting in the presence of direct factor Xa anticoagulants (DOACS) such as rivaroxaban, apixaban, and edoxaban.These factor Xa coagulants are taken by millions of patients world-wide for the prevention and treatment of thrombosis and stroke, but as a side effect severe bleeding often occurs. PseudoXa is capable of stopping and preventing such bleedings thus making the usage of DOACS much safer.
  • Dualyx — Dualyx engages in the discovery and development of biologicals for the treatment of autoimmune and rare diseases.
  • CatalYm — Catalym develops antibodies against a placental factor which is overexpressed by various tumour types.
Show more investments...

Inventures SA
VC Fund · Brussels, Brussels Hoofdstedelijk Gewest, Belgium · 1 investment in the past 12 months

Inventures is a European venture capital fund that builds a better world through a portfolio of investments in sustainable businesses.The firm has two funds: Inventures I & Inventures II.Inventures was created to support early stage smart and innovative European businesses, to support sustainable job growth and empower entrepreneurs.Inventures empowers citizenship co-investments through a crowdfunding platform, MyMicroInvest.

Show more...

Investment focus

  • Health Care, Manufacturing, Biotechnology
  • Series A, Seed, Funding Round
  • Belgium, France, United Kingdom

Portfolio highlights

  • BiOceanOr — BiOceanOr provides underwater weather stations to measure water quality. Their solutions provide informations from your exploitation in real-time. Receive alerts in real-time and take decisions with their preventive alert system.
  • myskillcamp — Myskillcamp is a digital learning platform and educational design support service. Myskillcamp supports their customers in the digital transformation of their company and the launch of their Digital Learning project. From the audit of needs to the design of engaging educational devices, through a pilot phase, they make a point of honor to adapt thedigital to the specificities of each and give it meaning.With their online platform, businesses can manage their learner communities and connect all their partners in one place. Their tool also allows businesses to structure training spaces by skills, trades, brands within camps. In parallel, businesses can create educational content from scratch, select a map in their marketplace, or plan sessions in-class. Businesses can organize the distribution of their training to a single learner or to a whole group.
  • Octave — A sustainable, cost-effective and reliable energy storage system with second-life batteries from electric vehicles.
Show more investments...

Be Angels
VC Fund · Louvain-la-neuve, Vlaams-Brabant, Belgium · 2 investments in the past 12 months

Early stage Entrepreneurs Coaching and FinancingOne of Europe's leading Business Angels Networks. We connect innovative growth companies to equity finance and coaching by experienced angel investors. The network is 250 members strong and has been assisting innovative entrepreneurs to find financing for more than 10 millions Euros in thelast 4 years.

Show more...

Investment focus

  • Software, Information Technology, SaaS
  • Seed, Pre-Seed, Funding Round
  • Belgium, France, Spain

Portfolio highlights

  • Savics — Savics offers digital solutions for health actors to improve their data management, disease diagnostics and GeneXpert connectivity.
  • DeftHedge — DeftHedge is an application addressed to business leaders, and CFOs facing volatility of foreign exchange market.
  • HeartKinetics — Heart failure diagnosis. HeartKinetics is a digital company dedicated to the remote detection and monitoring of patients with heart failure.
Show more investments...

Thuja Capital
VC Fund · Utrecht, Utrecht, The Netherlands · 1 investment in the past 12 months

Thuja Capital invests in early stage medical product innovations for diagnosis, cure, care or prevention.

Show more...

Investment focus

  • Biotechnology, Medical, Health Care
  • Funding Round, Series A, Seed
  • The Netherlands, Belgium, United States

Portfolio highlights

  • AstriVax — AstriVax aims for initial clinical validation of the platform technology, to develop a broad vaccination pipeline.
  • InnoSIGN — We are passionate to bring to market our OncoSIGNal pathway activity profiling technology contributing to a better understanding of disease mechanisms in oncology. OncoSIGNal enables next generation precision medicine by translating molecular data into functional cell behavior.
  • FundaMental Pharma — Use this space to add a brief description of your project.
Show more investments...

Spinventure
VC Fund · Angleur, Liege, Belgium

Spinventure supports the creation of spin-off companies that aim to industrialize and commercialize the result of scientific research. Spinventure was born from a collaboration between MEUSINVEST and the University of Liège. It is headquartered in Angleur, Belgium.

Show more...

Investment focus

  • Health Care, Biotechnology, Medical
  • Series A, Funding Round
  • Belgium

Portfolio highlights

  • Dim3 — Improve patients outcome - Deliver actionable insights - Save healthcare costs
  • Elysia — Elysia developed solution dedicated to quality control laboratories for the production of Radio Pharmaceuticals.
  • Convert Pharmaceuticals — Convert Pharmaceuticals develops prodrugs that are inert upon administration to patients, but transform into potent anti-cancer agents upon entering tumors.
Show more investments...

Noshaq
VC Fund · Liège, Liege, Belgium · 3 investments in the past 12 months

Noshaq offers financial services to help businesses develop.

Show more...

Investment focus

  • Medical, Analytics, Health Care
  • Funding Round, Series A
  • Belgium

Portfolio highlights

  • MyCellHub — MyCellHub.com is a pre-startup from the KULeuven in the biotherapeutics industry that aspires to reform the way cell production processes are organised. With a regulatory compliant Saas-platform for data management and analytics, we increase the efficiency of your manufacturing processes, provide actionable insights via cell culture specificprocess analytics and facilitate regulatory compliance by means of a real-time audit trail and automated batch records.
  • DeuterOncology — DeuterOncology is a preclinical-stage biotech company focusing on the development of a first-in-class dual MET and RAS pathway inhibitor for targeted cancer therapies.
  • Intressa Vascular — Intressa Vascular SA is a medical device company committed to providing innovative solutions to life-threatening cardiovascular conditions such as aortic dissection
Show more investments...

PMV
VC Fund · Brussels, Brussels Hoofdstedelijk Gewest, Belgium · 7 investments in the past 12 months

Do and dare company

Show more...

Investment focus

  • Software, Biotechnology, Health Care
  • Series A, Seed, Funding Round
  • Belgium, The Netherlands, United States

Portfolio highlights

  • IVEX — At IVEX, we are creating a safety co-pilot to make existing decision making platforms for autonomous driving safe. Our technology is based on years of research performed at KU Leuven University in Belgium. Our unique IP and team experience in behavior planning and functional safety enables the development of safe and reliable autonomous systems toreduce the traffic victims to zero by 2030.
  • Funkey — Kies je teambuilding uit meer dan 500 onvergetelijke activiteiten. Wij zorgen voor de volledige organisatie, incl. eventuele catering en overnachting.
  • dScribe — dScribe is your one-stop-shop to catalog, document and discover anything data-related.No more spending hours looking for the right data.No more doubting about the meaning of your KPIs.Reach the next level of data maturity by offering your users a single entry point to find, understand and access all your reports & data, no matter wherethey are stored.
Show more investments...

Mérieux Equity Partners
VC Fund · Lyon, Rhone-Alpes, France · 2 investments in the past 12 months

Mérieux Equity Partners (“MxEP”) is a management company dedicated to venture, growth and LBO investments in the healthcare and nutrition sectors. MxEP actively supports entrepreneurs and industrial companies with differentiated products and services, by providing privileged access to its expertise and international network. MxEP currently managesmore than €600m AUM and has recently launched a new vehicle MP3 of €350m dedicated to growth/LBO.

Show more...

Investment focus

  • Biotechnology, Medical, Health Care
  • Series A, Private Equity, Funding Round
  • France, Sweden, Belgium

Portfolio highlights

  • AstriVax — AstriVax aims for initial clinical validation of the platform technology, to develop a broad vaccination pipeline.
  • Mablink Bioscience — Mablink Bioscience is a biotechnology company specialized in the development of a new class of cancer drugs, called Antibody Drug Conjugate (ADC).
  • Broken String Biosciences — Our platform accelerates the characterisation of novel gene editing technologies to unlock the next wave of cell & gene therapies.
Show more investments...

Gimv
VC Fund · Antwerpen, Antwerpen, Belgium · 5 investments in the past 12 months

Gimv is a European investment company with over three decades of experience in private equity and venture capital.Gimv is listed on NYSE Euronext Brussels. Gimv currently manages around 1.8 billion EUR (including third party funds) of investments in 85 portfolio companies, which jointly realise a turnover of more than EUR 6 billion and employover 28,000 professionals.As a recognized market leader in selected investment platforms, Gimv identifies entrepreneurial and innovative companies with high-growth potential and supports them in their transformation into market leaders. Gimv’s four investment platforms are: Consumer 2020, Health & Care, Smart Industries and Sustainable Cities. Each of these platforms works with a skilled and dedicated team across Gimv’s home markets of the Benelux, France and Germany and can count on an extended international network of experts.More information on Gimv can be found on [www.gimv.com].

Show more...

Investment focus

  • Biotechnology, Health Care, Medical
  • Series B, Funding Round, Private Equity
  • Belgium, United States, France

Portfolio highlights

  • ERS — ERS is a semiconductor manufacturing company that offers thermal wafer testing and Air-Cool technology services.
  • Mediar Therapeutics — Mediar Therapeutics is a preclinical stage biotechnology company developing antibody-based therapeutics to halt fibrosis in a variety of organ systems, including lung, liver, kidney, and skin.
  • Complement Therapeutics — Turning powerful new Complement System insights into innovative treatments Developing the next generation of complement medicines [chevron-down] Turning powerful new Complement System insights into innovative treatments Developing the next generation of complement medicines [chevron-down] Geographic atrophy (late dry age-related macular degeneration) is a chronic eye condition that affects millions - and for which there is
Show more investments...

Quest for Growth
VC Fund · Leuven, Vlaams-Brabant, Belgium

Quest for Growth (QGPLF) is an Internet company located in 19 Lei, Leuven, Flanders, Belgium.

Show more...

Investment focus

  • Biotechnology, Software, Hardware
  • Funding Round, Series B, Series C
  • Belgium, France, The Netherlands

Portfolio highlights

  • Finquest — Finquest is the premier deal origination provider delivering personalized connections to its clients who seek M&A and direct investment opportunities in Europe, North America, and APAC.With a unique database, machine learning and a team of experts, Finquest provides targeted, curated and actionable connections, whilst maintaining completeconfidentiality throughout the process. With Finquest, clients can broaden their market access, creating a more efficient deal-making environment.Finquest is headquartered in Singapore and has offices in New York, London, Paris, Frankfurt, Luxembourg, Bangalore, and Hong Kong.
  • Sensolus — Introducing our smart, industrial-grade tracking solution. With battery life of up to ten years, and no additional infrastructure needed.
  • EclecticIQ — EclecticIQ is a global threat intelligence, hunting and response technology provider. Its clients are some of the most targeted organizations, globally. To build tomorrow’s defenses today, they have to understand the threats against them – and align their efforts and investments to mitigate their risks. EclecticIQ helps governments, largeenterprises and service providers manage threat intelligence, create situational awareness and adopt an intelligence-led cybersecurity approach. EclecticIQ extended its focus towards hunting and response with the acquisition of Polylogyx’s endpoint technology in 2020. Founded in 2014, EclecticIQ operates globally with offices across Europe, North America, and via value-add partners. More info: www.eclecticiq.com
Show more investments...

BIP Investment Partners
VC Fund · Luxembourg, Luxembourg, Luxembourg

BIP Investment Partners S.A. (BIP) is an independent financial holding company backed by Luxembourg family shareholders.Its activities are divided between providing private equity to businesses, particularly venture capital to startups, and investing in large, well-established Luxembourg-based businessesThe company was founded in 2000 as ajoint venture between Banque Générale du Luxembourg (BGL), later a part of Fortis Group, and now as the newly re-formed BGL and several smaller partners, under the name BGL Investment Partners, which was changed to 'BIP Investment Partners' in February 2006 after the rebranding of BGL. BIP is listed on the Luxembourg Stock Exchange, where it is one of the ten component companies of the main LuxX Index stock market index.

Show more...

Investment focus

  • Video, Medical, Software
  • Series A, Series B
  • Belgium

Portfolio highlights

  • XDC — CinemaNext is the largest cinema integrator company in EMEA (installation, digital, content, Dolby Atmos, laser projectors, NOC, maintenance & support).
  • Movetis — I found a great domain name for sale on Dan.com. Check it out!
Show more investments...

New Rhein
VC Fund · 1 investment in the past 12 months

New Rhein is a Philadelphia based healthcare venture capital firm focused on repurposed assets.

Show more...

Investment focus

  • Medical, Biotechnology, Health Care
  • Series A, Series B, Seed
  • United States, Israel, Belgium

Portfolio highlights

  • Theranica — Theranica is a medical device company that has combined neuromodulation therapy with modern wireless technology to develop proprietary wearable solutions that address various medical conditions and disease states. The noninvasive and therapeutic 'smart' patches are controlled by a smartphone app to allow for personalized, portable, andaffordable care. The patch consists of a proprietary 'smart' chip that delivers electrical pulses to neuro-modulate the sensory nerves under the skin. The first application of the technology is for treatment of migraine headaches.
  • Corsair Pharma — Corsair Pharma is developing transformative solutions to improve the therapeutic profile of medications and provide superior treatment options for patients.
  • Butterfly Medical — Butterfly, Butterfly Medical, BPH Treatment, BPH Office Procedure, Idan Geva, Minimally Invasive BPH, Prostate, Enlarged Prostate, Bening Prostate Hyperplasia, Urology
Show more investments...

Financière Spin-Off Luxembourgeoise
VC Fund

Specializes in spin-off and spin-out investments.

Show more...

Investment focus

  • Medical, Health Care, Medical Device
  • Series A
  • Belgium

Portfolio highlights

  • Synergia Medical — Synergia Medical aims at developing and commercializing next generation neurostimulation devices. It relies on a seasoned management team with extensive experience in developing implantable neurostimulators.In only three years time, the company became ISO13485 certified, created and sold an OEM external neurostimulator for a motorized amputeeprosthesis arm and developed its first version of the NAOS platform.Supported by private investors and public research grants, the company has quickly grown to a team of thirteen highly skilled multidisciplinary professionals.
Show more investments...

LeanSquare
VC Fund · Liège, Liege, Belgium · 2 investments in the past 12 months

New Economy Startups Investor & Accelerator

Show more...

Investment focus

  • Software, Music, Internet
  • Seed, Funding Round, Series A
  • Belgium, France, United States

Portfolio highlights

  • Zapfloor — Zapfloor is the number one workspace management software for coworking spaces, serviced offices and corporate workspaces in Europe.
  • ClimateCamp — Looking for a sustainable way to collaborate with your suppliers on emissions reduction projects? Look no further than our platform - Book a demo for free!
  • Streamforge — Streamforge is the technology-first, turnkey solution for all of your influencer marketing needs.
Show more investments...

NV Industriebank LIOF
VC Fund · Maastricht, Limburg, The Netherlands · 1 investment in the past 12 months

NV Industriebank LIOF is the Limburg development and investment company. LIOF contributes to the prosperity of the province with an ongoing program to strengthen the province's economic base. LIOF targets industry and the dynamic service sector.Its four core activities are Acquisition, Participation, Development/Innovation andBusiness Parks, as these relate to the location/relocation of (foreign) companies, venture capital participation in Limburg companies with prospects, the development/implementation of programs and projects to sharpen the competitive edge of Limburg business and the coordination of the development of new business parks.LIOF has a strategic approach which targets opportunities for long-term economic development. In this it has a bridging role between government and business. LIOF is an ambitious professional organization and speaks the language that business understands.

Show more...

Investment focus

  • Biotechnology, Medical, Health Care
  • Funding Round, Series A, Seed
  • The Netherlands, Belgium

Portfolio highlights

  • Embrosa — Embrosa specializes in delivering marketing content from the brand's HQ to local retailers across the globe.
  • Neuroplast — Neuro-regenerative personalized medicine is one of the most promising therapies, which needs dedicated uniform standards and regulations.
  • Aerial Precision — Experience the most streamlined and user-friendly workflow, seamlessly transforming iPad LiDAR data processing into exceptional deliverables.
Show more investments...

BNP Paribas Fortis
VC Fund · Brussels, Brussels Hoofdstedelijk Gewest, Belgium · 2 investments in the past 12 months

BNP Paribas Fortis is a bank that provides personal and business banking services.

Show more...

Investment focus

  • Biotechnology, Logistics, Software
  • Debt Financing, Funding Round, Series B
  • Belgium, United States, Germany

Portfolio highlights

  • Aircastle — Aircastle is a global company that acquires, leases and sells high-utility commercial jet aircraft to customers throughout the world. High-utility aircraft are generally modern, operationally efficient jets with a large operator base and long useful lives. As of December 31, 2013, Aircastle's aircraft portfolio consisted of 162 aircraft onlease with 64 customers located in 37 countries. From time to time, we also make investments in other aviation assets, including debt securities secured by commercial jet aircraft.Their business is managed by a team of aviation professionals with extensive industry experience. Through servicing offices in the US, Ireland and Singapore, they provide their airline customers with an exceptional level of service and their investors with global coverage and local market knowledge. Aircastle employs a balanced approach to investment and capitalization, factoring in industry cyclicality and other global and regional market dynamics. They focus on a long-term investment horizon. Their diversified fleet includes Boeing and Airbus narrow and mid-body aircraft including both passenger and freighter applications. Their professionals have extensive experience with aircraft finance, leasing and investment management.
  • MobieTrain — The mobile microlearning platform of Mobietrain improves knowledge retention with personalised, gamified learning to boost your sales.
  • Global Infrastructure Partners (GIP) — A leading global, independent infrastructure fund manager.
Show more investments...

Yonjin Venture
VC Fund · Cambridge, Massachusetts, United States · 2 investments in the past 12 months

Yonjin Venture is an investment firm specializing in investing in early and mid-stage life science companies.It focuses on the innovative technologies in therapeutics, diagnostics, and medical devices. The firm is a sub-organization of Yongjin Group and the sister firm of Yonghua Capital.The Cambridge, Massachusetts-based firm was establishedin 2018.

Show more...

Investment focus

  • Biotechnology, Health Care, Medical
  • Series B, Series A, Series C
  • United States, China, Israel

Portfolio highlights

  • HistoSonics — HistoSonics provides the Edison Platform, which uses advanced imaging and proprietary sensing technology to deliver non-invasive, personalized treatments with precision and control, and uses the science of histotripsy and focused sound energy to generate pressures to liquify and completely destroy targeted tissues at sub-cellular levels.
  • Intressa Vascular — Intressa Vascular SA is a medical device company committed to providing innovative solutions to life-threatening cardiovascular conditions such as aortic dissection
  • Bluejay Therapeutics — At Bluejay, we are discovering life-changing medicines and cures for people with viral and liver diseases, starting with chronic hepatitis B (CHB) and chronic hepatitis D (CHD).
Show more investments...

Delta Partners
VC Fund · Leopardstown, Dublin, Ireland · 5 investments in the past 12 months

Early stage VC investments and funding for start-ups / founders in Ireland.

Show more...

Investment focus

  • Software, Information Technology, Health Care
  • Funding Round, Seed, Series A
  • Ireland, United States, United Kingdom

Portfolio highlights

  • Kayna — Kayna is an insurance distribution company that collaborates with vertical SaaS platforms and utilises data to offer insurance services.
  • Tailr — Redefining production for the clothing industry.
  • Recruitroo — Recruitroo is a international recruitment agency that uses technologies to streamline and improve the international recruitment process for both companies and candidates.
Show more investments...

Vinnof
VC Fund · Brussels, Brussels Hoofdstedelijk Gewest, Belgium

Vinnof is a venture capital firm that offers seed capital to innovative, early-stage startups based in Flanders, Belgium.

Show more...

Investment focus

  • Biotechnology, Health Care, Medical
  • Series A, Series B, Funding Round
  • Belgium, United Kingdom

Portfolio highlights

  • Apitope — Worg Pharmaceuticals has acquired all of the assets of Apitope International NV. You will be automatically redirected to www.worgpharma.com in ? seconds or click the link now. Worg Pharmaceuticals (Hangzhou) Co., Ltd.
  • Complix — Complix is a biopharmaceutical company focused on the discovery and development of Alphabodiesâ„¢, a novel class of biopharmaceuticals that offer significant advantages over existing protein based therapies. Alphabodiesâ„¢ bind with high affinity to a wide range of disease targets and are particularly suited to address certain targets that aredifficult to reach with antibodies or other types of protein scaffolds. Due to their unique stability and versatility Alphabodiesâ„¢ can be delivered via alternative non-injectable routes of administration, unlike most therapeutic proteins.
  • Okapi Sciences — Okapi Sciences NV, a Belgium-based company with a proprietary pet therapeutics antiviral platform and five clinical/development stage candidates for treating important viral diseases. The strategic acquisition of Okapi further enhances Aratana's leadership position in pet therapeutics by bringing with it a unique combination ofindividuals, strong relationships with academic institutions, novel technologies and products, and favorable geographic location. Aratana plans to continue to advance the current Okapi pipeline of high value antiviral drugs, including its feline herpes and feline immunodeficiency virus franchises.
Show more investments...

Sofinnova Investments
VC Fund · Menlo Park, California, United States · 6 investments in the past 12 months

Sofinnova deploys human and financial capital to turn dreams into drugs. We are a clinical-stage biopharmaceutical venture capital firm with approximately $2B in assets under management and committed capital.

Show more...

Investment focus

  • Biotechnology, Health Care, Pharmaceutical
  • Series B, Series A, Series C
  • United States, France, United Kingdom

Portfolio highlights

  • Star Therapeutics — Star Therapeutics mission is to develop therapies for as many diseases as possible for millions of patients.
  • Rapport Therapeutics — Precision medicines to match the complexity of the human brain.
  • Alkeus Pharmaceuticals — Alkeus Pharmaceuticals is a Boston-based startup focused on treatments for serious ophthalmic conditions.
Show more investments...

EQT life science
VC Fund · Amsterdam, Noord-Holland, The Netherlands · 6 investments in the past 12 months

EQT life science develops innovative medicines, devices, and tools to address the single important thing that matters to the preservation of health. The organization believes that such opportunities add value to all stakeholders.

Show more...

Investment focus

  • Biotechnology, Health Care, Therapeutics
  • Series A, Series B, Series C
  • United States, The Netherlands, Switzerland

Portfolio highlights

  • VarmX — VarmX is a pharmaceutical spin-off from the Leiden University Medical Center. The mission of VarmX is to develop and manufacture therapeutic proteins to instantaneously restore blood clotting in bleeding patients. The lead product in the pipeline of VarmX is PseudoXa. PseudoXa is a modified recombinant human coagulation factor X which is capable ofimmediately restoring blood clotting in the presence of direct factor Xa anticoagulants (DOACS) such as rivaroxaban, apixaban, and edoxaban.These factor Xa coagulants are taken by millions of patients world-wide for the prevention and treatment of thrombosis and stroke, but as a side effect severe bleeding often occurs. PseudoXa is capable of stopping and preventing such bleedings thus making the usage of DOACS much safer.
  • Xeltis — Xeltis is pioneering a restorative approach in cardiovascular therapy.
  • Evommune — Evommune is taking a tissue-based approach to advance insights and accelerate the development of transformative medicines in inflammatory diseases.
Show more investments...

CPH Banque
VC Fund · Tournai, Basse-Normandie, France · 1 investment in the past 12 months

CPH Banque is a financial services company that provides loan, head full projects and mobile banking services.

Show more...

Investment focus

  • Health Care, Medical, Training
  • Funding Round, Series B
  • Belgium

Portfolio highlights

  • OncoDNA — OncoDNA, with over 60 years’ expertise in medical diagnostics, was founded by a team of experts with many years of experience in DNA sequencing and diagnostic analyses in oncology.
  • I-care Group — I-care offers products, training, and services to its industrial customers.
  • Intressa Vascular — Intressa Vascular SA is a medical device company committed to providing innovative solutions to life-threatening cardiovascular conditions such as aortic dissection
Show more investments...

Forbion Capital Partners
VC Fund · Naarden, Noord-Holland, The Netherlands · 8 investments in the past 12 months

Impacting the future of medicine.

Show more...

Investment focus

  • Biotechnology, Health Care, Medical
  • Series B, Series A, Series C
  • United States, United Kingdom, The Netherlands

Portfolio highlights

  • Mariana Oncology — Mariana Oncology is a biotechnology research industry.
  • Seamless Therapeutics — Seamless Therapeutics is changing the paradigm of gene editing through a pioneering approach to restore health in patients with severe conditions in a safe and precise manner. Seamless technology platform unlocks the reprogramming of recombinases, a highly versatile class of enzymes.
  • Complement Therapeutics — Turning powerful new Complement System insights into innovative treatments Developing the next generation of complement medicines [chevron-down] Turning powerful new Complement System insights into innovative treatments Developing the next generation of complement medicines [chevron-down] Geographic atrophy (late dry age-related macular degeneration) is a chronic eye condition that affects millions - and for which there is
Show more investments...

Sofinnova Partners
VC Fund · Paris, Ile-de-France, France · 20 investments in the past 12 months

Sofinnova Partners is a leading European venture capital firm in life sciences, specializing in healthcare and sustainability. Based in Paris, London and Milan, the firm brings together a team of professionals from all over the world with strong scientific, medical and business expertise.

Show more...

Investment focus

  • Biotechnology, Health Care, Medical
  • Series A, Series B, Series C
  • France, United States, United Kingdom

Portfolio highlights

  • AAVantgarde Bio — AAVantgarde Bio is developing gene therapies for inherited retinal disorders.
  • Crescendo Biologics — Crescendo Biologics is a new Cambridge-based company whose vision is to deliver next-generation antibody therapeutics based on novel class-leading platforms.The focus of the company is on developing platforms that will address key issues in generating high-affinity, soluble, human VH antibody fragments. These are the smallest fragments thatretain antibody binding, and have many desirable properties as potential therapeutics. Crescendo will then utilise these platforms for product development of in-house targets or in partnership with other companies.
  • Tenpoint Therapeutics — Tenpoint Therapeutics is a biotechnology company pursuing vision-restoring engineered cell-based therapeutics.
Show more investments...

Hunza Ventures
VC Fund · Luxembourg, Luxembourg, Luxembourg

Hunza Ventures is a venture capital firm incorporated in 1998 in Luxemburg. The firm has focused its investments on early and mid-stage life sciences and IT companies with outstanding growth prospects.Hunza Ventures has built a large and well-balanced portfolio based on the strong entrepreneurial experience of the fund’s shareholders andmanagers. Since inception, Hunza Ventures has backed 20 companies in Belgium, Israel, USA and Singapore.Hunza Ventures has raised two funds:Hunza Ventures raised €15 million. The fund made 14 venture investments and is fully invested. A series of companies have successfully been divested.Hunza Ventures II raised €6.25 million in October 2008. This fund is actively investing and is currently raising additional capital.

Show more...

Investment focus

  • Medical, Health Care, Biotechnology
  • Series A, Funding Round
  • Belgium, United States

Portfolio highlights

  • ITeos Therapeutics — iTeos Therapeutics is pioneering the discovery and development of highly differentiated immuno-oncology therapeutics for cancer patients.
  • Formac Pharmaceuticals — Formac is a spin-off company from the University of Leuven, Belgium (K.U.Leuven), from which it has obtained the exclusive and worldwide rights to develop and commercialise ordered mesoporous silica materials for the delivery of poorly soluble API's. The company was incorporated on 3 October 2007 and is privately owned. The main shareholdersof Formac are K.U.Leuven, Allegro Investment Fund, Hunza Ventures, Gemma Frisius Fonds K.U.Leuven, Vinnof PMV and Life Sciences Research Partners VZW (formerly D. Collen Foundation).Since its incorporation Formac has signed more than 40 feasibility agreements with Tier 1 Pharma companies and SMEs in the field of human and veterinary medicine. To date, Formac is the only company that demonstrated the clinical relevancy of the silica based technology in a clinical setting.
Show more investments...

Investsud
VC Fund · Marche-en-famenne, Luxembourg, Belgium · 5 investments in the past 12 months

Investsud is a capital firm that works on investments in different industries including food, general industry, and technological startup.

Show more...

Investment focus

  • Biotechnology, Medical, SaaS
  • Series A, Seed, Series B
  • Belgium, France

Portfolio highlights

  • cikisi — Specialized in Web Intelligence (collecting, searching and filtering web information). Help companies and organizations to take advantage of Web information that are relevant to their development. Develops and commercializes Cikisi WMT, a Web Intelligence Solution.
  • Curvo — Curvo is the easiest way for young Belgians to passively invest through index funds.
  • AbolerIS Pharma — AbolerIS Pharma aims to develop novel and unique therapeutic approaches to induce immune tolerance.
Show more investments...

Ackermans & van Haaren
VC Fund · Antwerpen, Antwerpen, Belgium

Ackermans & van Haaren is a diversified group active in 5 segments: Marine Engineering & Infrastructure; Private Banking; Real Estate, Leisure & Senior Care; Energy & Resources; Development Capital. Marine Engineering & Infrastructure: DEME, one of the largest dredging companies in the world - Algemene Aannemingen Van Laere,a leading contractor in Belgium. Ackermans & van Haaren is an independent and diversified group aiming at creating shareholder value through long-term investments in a limited number of companies with growth potential on an international level.

Show more...

Investment focus

  • Biotechnology, Health Care, Medical
  • Series B, Series A, Series C
  • Belgium, India

Portfolio highlights

  • AstriVax — AstriVax aims for initial clinical validation of the platform technology, to develop a broad vaccination pipeline.
  • Medikabazaar — Medikabazaar is an online B2B marketspace for medical supplies and equipment. They are a single point of contact for all product-based needs, enabling medical institutions and individual practitioners alike to cut down on operational costs and making the best global brands available locally, all aided with the miracle that goes by the name oftechnology. They are connected with more than 50,000 medical establishments, 1,50,000 Independent Practitioners, and have partnered with 13,000+ suppliers all over India including ones in Tier 2, Tier 3 cities, and remoter locations to establish a strong foothold in India and simultaneously earn the respect of our clients. With the power of technology, we organized a haywire market in a country with perhaps the largest and most complex geographical structure in the world for this purpose. Our last-mile delivery system and 26 strategically placed Fulfilment Centres across India enable us to deliver essential medical supplies to healthcare facilities and help them nurture quality and timely patient care. With our first international office in the Middle East, we are transcending boundaries to deliver care, everywhere.
  • Indigo Diabetes — Revolutionizing the management of chronic disease.
Show more investments...

High-Tech Grunderfonds
VC Fund · Bonn, Nordrhein-Westfalen, Germany · 64 investments in the past 12 months

High-Tech Gründerfonds (HTGF) is a seed investor that finances high-potential, tech-driven startups. With EUR 895.5 million in total investment volume across three funds and an international network of partners, HTGF has already helped forge more than 500 startups since 2005. Driven by their expertise, entrepreneurial spirit, and passion, its teamof experienced investment managers and startup experts help guide the development of young companies. HTGF’s focus is on high-tech startups in a range of sectors, including software, media, internet, hardware, automation, health care, chemistry, and life sciences.To date, external investors have injected over EUR 2 billion into the HTGF portfolio via about 1,400 follow-on financing rounds. HTGF has also successfully sold interests in more than 100 companies. Investors in this public-private partnership include the Federal Ministry For Economic Affairs and Energy, the KfW Banking Group, and Fraunhofer-Gesellschaft e.V., as well as the companies ALTANA, BASF, BAYER, B.Braun, Boehringer Ingelheim, Robert Bosch, BÜFA, CEWE, Deutsche Post DHL, Dräger, Drillisch AG, EVONIK, EWE AG, FOND OF Haniel, Hettich, Knauf, Körber, LANXESS, media + more venture Beteiligungs GmbH & Co. KG, PHOENIX CONTACT, Postbank, QIAGEN, RWE Generation SE, SAP, Schufa, Schwarz Gruppe, STIHL, Thüga, Vector Informatik, WACKER and Wilh. Werhahn KG.

Show more...

Investment focus

  • Software, Information Technology, Biotechnology
  • Seed, Series A, Funding Round
  • Germany, Switzerland, United States

Portfolio highlights

  • Inovedis — Inovedis offers innovative solutions in medical technology that contribute both to optimized patient care as well as time and cost reductions in the healthcare sector.
  • Resourcify — Mein Recycling is developed by Resourcify GmbH from Hamburg. The app is the easiest solution for businesses to easily manage all of their waste, collections, and recyclers in one app, and for waste management companies to seamlessly connect with their customers online. Their vision is zero-waste: enabled with the digital transformation of the wastesector as the foundation for the circular economy.
  • traceless materials — traceless materials offer a holistically sustainable alternative to plastics: 100% biobased on plant residues, compostable under natural conditions, and free of toxic chemicals. For a future free of pollution and waste!
Show more investments...

Flanders Future Techfund
VC Fund · 1 investment in the past 12 months

Flanders Future Techfund operates as an investment firm.

Show more...

Investment focus

  • Medical, Semiconductor, Clinical Trials
  • Seed
  • Belgium

Portfolio highlights

  • AstriVax — AstriVax aims for initial clinical validation of the platform technology, to develop a broad vaccination pipeline.
  • Swave Photonics — Our mission is to bring the metaverse to life and enable display manufacturers and content creators to disrupt the visualization market with immersive, ultra-high-resolution, lifelike, true holographic displays.
Show more investments...

Dental Innovation Alliance
VC Fund · Raleigh, North Carolina, United States · 3 investments in the past 12 months

Dental Innovation Alliance (DIA) is a venture capital company that invests in, advises on, and accelerates the growth of early-stage companies that are transforming dentistry through technology.

Show more...

Investment focus

  • Software, SaaS, Dental
  • Seed, Series A, Funding Round
  • Belgium, Germany, United States

Portfolio highlights

  • Relu — Integrate Relu's automatic 3D segmentations seamlessly into your CBCT software.
  • UptimeHealth — UptimeHealth, headquartered in Boston, MA, is a fast-growing software startup that simplifies medical device service events, purchases, and compliance practices through automation and predictive analytics.
  • Dentognostics GmbH — Dentognostics is a reasearch based firm that offers medicine and dentistry innovative and powerful systems for diagnostics, and therapy.
Show more investments...

SFPI-FPIM
VC Fund · Brussels, Brussels Hoofdstedelijk Gewest, Belgium · 3 investments in the past 12 months

The Federal Holding and Investment Company (SFPI-FPIM) centrally manages the federal government’s shareholdings, cooperates with the government on specific projects and pursues its own investment policy in the interests of the Belgian economy.

Show more...

Investment focus

  • Health Care, Biotechnology, Medical
  • Funding Round, Series B, Series A
  • Belgium, United States, France

Portfolio highlights

  • Cohabs — Cohabs is a network of beautiful shared homes for nomads around the world. It provides flexible and fully furnished accommodations through a network of sustainable and community-driven shared homes. Cohabs prioritizes the experience of its members through a tech-centric and flexible process. They build a thriving community through monthly events,dinners, and other parties.
  • Univercells — Univercells delivers novel biomanufacturing platforms and solutions aiming at making biologics available & affordable to all.
  • Tangent Works — Create predictive models in seconds for faster and better forecasting & anomaly detection with TIM InstantML.
Show more investments...

Limburg Startup
VC Fund · Maastricht, Limburg, The Netherlands

Limburg Ventures is a venture capital fund that invests in startups in life sciences and related fields of advanced chemicals and materials.

Show more...

Investment focus

  • Biotechnology, Medical, Health Care
  • Series A, Series B, Funding Round
  • The Netherlands, France, Belgium

Portfolio highlights

  • Ekompany — Ekompany is a Dutch producer of coated mineral fertilisers (CRF) with sales operations in Western Europe and Far East. Their team of professionals possesses the latest knowledge across the chemical, agricultural and horticultural fields and have decades of experience in designing, producing and supplying specialty fertilisers supported by the rightadvice.Established in 2010, their unique production facility in Born was opened for production in September 2013. Ekompany has developed a patented coating process that is clean, safe, continuous and more energy efficient than existing ones. This way they can produce intelligent Controlled Release Fertilisers that are both technologically advanced and economical for wider use in agriculture and horticulture. Learn more about their Ekote portfolio which has proven its benefits in more than 200 field trials internationally.
  • FABPulous — FABPulous is an innovative healthcare company which develops and markets solutions for diagnostics in primary care and emergency medicine.FABPulous is a company based in The Netherlands. It was spun out of Maastricht University at the end of 2008. In December 2009 FABPulous closed a first equity financing round co-led by Thuja Capital, HealthInnovations, Limburg Ventures and NV Industriebank LIOF.The company has developed a technology that allows a simple, robust and ultra-rapid diluted plasma preparation from a drop of blood. This offers great advantages in the point-of-care (POC) and home testing setting, over current technology. It concerns a disposable plasma preparation device that can be integrated with many IVD detection platforms, such lateral flow devices. The first product application under development by FABPulous is a rapid test for the cardiac biomarker heart-type fatty acid binding protein (H-FABP), to aid in the first-line diagnosis of acute myocardial infarction.
  • Kriya Materials — Kriya Materials is the innovative developer and manufacturer of various metal oxide nano particles as well as their downstream dispersions and functional coating products thereof. Coatings play an important role in our everyday life, although often not recognized by those who do not master the art. Coatings are a big market and many products fallunder this category. Kriya Materials focuses itself on the development and manufacturing of various nano metal oxides which it uses internally for the development and production of very high end coatings.The coatings made by Kriya Materials are applied in a wide range of markets, some examples are the Plasma Panel and LCD industry, from Smartphone to touch panels to glass surfaces.
Show more investments...

The CoFoundry
VC Fund · Antwerp, Antwerpen, Belgium

The CoFoundry helps entrepreneurs transform their ideas into sustainable companies. Some say we cut through the funding hype and work hard to give your business a sustainable future.

Show more...

Investment focus

  • Software, Network Security, SaaS
  • Seed, Series A, Funding Round
  • Belgium, The Netherlands, United States

Portfolio highlights

  • Aloxy — Aloxy offers reliable IIot solutions tailored to the needs of the process industry. Our valve sensor provides an open and close indication of manual valves.
  • MyCellHub — MyCellHub.com is a pre-startup from the KULeuven in the biotherapeutics industry that aspires to reform the way cell production processes are organised. With a regulatory compliant Saas-platform for data management and analytics, we increase the efficiency of your manufacturing processes, provide actionable insights via cell culture specificprocess analytics and facilitate regulatory compliance by means of a real-time audit trail and automated batch records.
  • Vaultspeed — Save your teams months of headache with a no-code approach to automate your multi-source data integration, Data Vault modeling & ETL/DDL code generation.
Show more investments...
Investors by industry
Investors by country
VC (Venture Capital) Funds in Belgium by industry

Close your round

Find who invests in your industry, stage, and region in our 200k+ database with AI-powered matching.

Find investors — It's Free!

Join 21,000+ founders from:

Y Combinator Techstars Antler Pioneer On Deck